Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (<scp>UNCOVER</scp>‐1, <scp>UNCOVER</scp>‐2 and <scp>UNCOVER</scp>‐3)Alan Menter, Kristian Reich, Richard B. Warren et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 74
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With PsoriasisLourdes M. Pérez-Chada, John S. Barbieri, Andrew Creadore et al.|JAMA Dermatology|2024Cited by 17